Gilead Sciences is a biopharmaceutical company based in California that researches, develops and sells medicines, chiefly for viral infections. Its products include treatments for HIV and hepatitis C, along with therapies for other serious conditions such as certain cancers and inflammatory diseases. The company serves patients and healthcare providers through hospitals, clinics and pharmacies, working with health systems and governments around the world to make its medicines available.
The shares are listed on the XETRA Stock Exchange in Germany under the code GIS, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Strong price profile
Ranks #41 of 701 on the XETRA Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Germany yet.
TrendStrong
85/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average16.9%
From 52-week high-2.2%
MomentumStrong
85/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return21.3%
6-month return24.8%
12-month, skipping last month29.0%
Stability (higher is calmer)Strong
82/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)24.8%
Worst drawdown, 1 year (smaller is calmer)-18.6%
LiquidityWeak
47/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.12M EUR
Zero-volume days0.0%
IncomeFair
63/100
Dividend is typical for this exchange.
See the numbers →
Dividend yield1.9%
Years with dividends6
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Germany when fundamentals data for this market is added. All Germany stocks.
52-wk range 98.96 – 142.80Daily closes, split-adjusted
Signals
50-day average129.54
200-day average118.89
Golden/death cross (60d)Golden, 51 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)3.05
Technical summary
Daily
Strongly bullish
12 bullish · 4 neutral · 0 bearish
Weekly
Strongly bullish
11 bullish · 1 neutral · 0 bearish
Monthly
Strongly bullish
7 bullish · 0 neutral · 1 bearish
Moving averages (daily)
SMA 10
137.1
Bullish
EMA 10
136.8
Bullish
SMA 20
133.9
Bullish
EMA 20
134.6
Bullish
SMA 50
129.5
Bullish
EMA 50
129.6
Bullish
SMA 100
121.0
Bullish
EMA 100
124.3
Bullish
SMA 200
118.9
Bullish
EMA 200
118.2
Bullish
Oscillators (daily)
RSI (14)
60.36
Neutral
MACD (12, 26)
2.86
Bullish
Momentum (12)
8.23
Bullish
Stochastic %K (14)
75.13
Neutral
Williams %R (14)
-24.87
Neutral
CCI (20)
92.70
Neutral
Pivot points (classic, last session)
S3
133.9
S2
135.2
S1
137.1
Pivot
138.3
R1
140.2
R2
141.5
R3
143.3
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
2.89 USD
Yield on today's price
1.85%
Frequency
Quarterly
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
0.7294
0.7294
0.7294
0.7027
0.7027
0.7027
0.7027
0.6849
0.6849
0.6849
0.6849
0.6671
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in EUR. Educational only, not financial advice.
